6918 — A Plus Biotechnology Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for A Plus Biotechnology Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	290	306	239	320	392
Net Total Accounts Receivable
Net Total Receivables	136	136	150	144	185
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	713	761	714	770	897
Net Property, Plant And Equipment	18.2	233	260	259	252
Net Intangible Assets
Other Long Term Assets
Total Assets	930	1,206	1,175	1,114	1,177
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	154	203	174	143	163
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	162	362	297	243	258
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	768	844	878	870	919
Total Liabilities & Shareholders' Equity	930	1,206	1,175	1,114	1,177
Total Common Shares Outstanding